SELECTIVE NEURODEGENERATION, NEUROPATHOLOGY AND SYMPTOM PROFILES IN HUNTINGTON'S DISEASE

被引:0
作者
Waldvogel, Henry J. [1 ,2 ]
Thu, Doris [3 ]
Hogg, Virginia [2 ,4 ]
Tippett, Lynette [2 ,4 ]
Faull, Richard L. M. [1 ,2 ]
机构
[1] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand
[3] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland
[4] Univ Auckland, Dept Psychol, Auckland, New Zealand
来源
TANDEM REPEAT POLYMORPHISMS: GENETIC PLASTICITY, NEURAL DIVERSITY AND DISEASE | 2012年 / 769卷
关键词
CELL-CELL INTERACTIONS; CAG REPEAT LENGTH; BASAL GANGLIA; MOUSE MODEL; NEUROTROPHIC FACTOR; PROJECTION NEURONS; CLINICAL-FEATURES; DIFFERENTIAL LOSS; STRIATAL NEURONS; CEREBRAL-CORTEX;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG repeat expansion in exon 1 of the Huntington gene (HD) also known as IT15. Despite the disease being caused by dysfunction of a single gene, expressed as an expanded polyglutamine in the huntingtin protein, there is a major variability in the symptom profile of patients with Huntington's disease as well as great variability in the neuropathology. The symptoms vary throughout the course of the disease and vary greatly between cases. These symptoms present as varying degrees of involuntary movements, mood, personality changes, cognitive changes and dementia. To determine whether there is a morphological basis for this symptom variability, recent studies have investigated the cellular and neurochemical changes in the striatum and cerebral cortex in the human brain to determine whether there is a link between the pathology in these regions and the symptomatology shown by individual cases. These studies together revealed that cases showing mainly mood symptom profiles correlated with marked degeneration in the strio-somal compartment of the striatum, or in the anterior cingulate gyrus of the cerebral cortex. In contrast, in cases with mainly motor symptoms neurodegeneration was especially marked in the primary motor cortex with variable degeneration in both the striosomes and matrix compartments of the striatum. These studies suggest that the variable degeneration of the striatum and cerebral cortex correlates with the variable profiles of Huntington's disease.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 77 条
[1]   EXCITATORY AMINO-ACID BINDING-SITES IN THE BASAL GANGLIA OF THE RAT - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
ALBIN, RL ;
MAKOWIEC, RL ;
HOLLINGSWORTH, ZR ;
DURE, LS ;
PENNEY, JB ;
YOUNG, AB .
NEUROSCIENCE, 1992, 46 (01) :35-48
[2]   Anterior cingulate dysfunction in geriatric depression [J].
Alexopoulos, George S. ;
Gunning-Dixon, Faith M. ;
Latoussakis, Vassilios ;
Kanellopoulos, Dora ;
Murphy, Christopher F. .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (04) :347-355
[3]   Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington's disease [J].
Allen, K. L. ;
Waldvogel, H. J. ;
Glass, M. ;
Faull, R. L. M. .
JOURNAL OF CHEMICAL NEUROANATOMY, 2009, 37 (04) :266-281
[4]   Altered cortical glutamate receptor function in the r6/2 model of Huntington's disease [J].
André, VM ;
Cepeda, C ;
Venegas, A ;
Gomez, Y ;
Levine, MS .
JOURNAL OF NEUROPHYSIOLOGY, 2006, 95 (04) :2108-2119
[5]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[6]   Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study [J].
Augood, SJ ;
Faull, RLM ;
Love, DR ;
Emson, PC .
NEUROSCIENCE, 1996, 72 (04) :1023-1036
[7]   THE NEUROPSYCHOLOGY OF HUNTINGTONS-DISEASE [J].
BRANDT, J ;
BUTTERS, N .
TRENDS IN NEUROSCIENCES, 1986, 9 (03) :118-120
[8]   Loss of normal huntingtin function: new developments in Huntington's disease research [J].
Cattaneo, E ;
Rigamonti, D ;
Goffredo, D ;
Zuccato, C ;
Squitieri, F ;
Sipione, S .
TRENDS IN NEUROSCIENCES, 2001, 24 (03) :182-188
[9]   The corticostriatal pathway in Huntington's disease [J].
Cepeda, Carlos ;
Wu, Nanping ;
Andre, Veronique M. ;
Cummings, Damian M. ;
Levine, Michael S. .
PROGRESS IN NEUROBIOLOGY, 2007, 81 (5-6) :253-271
[10]   Transcriptional dysregulation in Huntington's disease [J].
Cha, JHJ .
TRENDS IN NEUROSCIENCES, 2000, 23 (09) :387-392